Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · Real-Time Price · USD
3.610
+0.040 (1.12%)
At close: Sep 17, 2025, 4:00 PM EDT
3.640
+0.030 (0.83%)
Pre-market: Sep 18, 2025, 8:03 AM EDT
Clearside Biomedical Market Cap
Clearside Biomedical has a market cap or net worth of $18.89 million as of September 18, 2025. Its market cap has decreased by -74.97% in one year.
Market Cap
18.89M
Enterprise Value
65.75M
1-Year Change
-74.97%
Ranking
Category
Stock Price
$3.61
Market Cap Chart
Since June 2, 2016, Clearside Biomedical's market cap has decreased from $142.00M to $18.89M, a decrease of -86.69%. That is a compound annual growth rate of -19.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 18.90M | -73.79% |
| Dec 31, 2024 | 72.10M | -1.23% |
| Dec 29, 2023 | 73.00M | 8.31% |
| Dec 30, 2022 | 67.40M | -58.93% |
| Dec 31, 2021 | 164.10M | 23.85% |
| Dec 31, 2020 | 132.50M | 11.06% |
| Dec 31, 2019 | 119.30M | 247.81% |
| Dec 31, 2018 | 34.30M | -80.67% |
| Dec 29, 2017 | 177.40M | -3.53% |
| Dec 30, 2016 | 183.90M | 29.51% |
| Jun 2, 2016 | 142.00M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |